<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32033983</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">2373-2822</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Season>Jan/Feb</Season></PubDate></JournalIssue><Title>eNeuro</Title><ISOAbbreviation>eNeuro</ISOAbbreviation></Journal><ArticleTitle>Sex-Specific Differences in Motor-Unit Remodeling in a Mouse Model of ALS.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">ENEURO.0388-19.2020</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1523/ENEURO.0388-19.2020</ELocationID><Abstract><AbstractText>Progressive loss of neuromuscular junctions (NMJs) is an early event in amyotrophic lateral sclerosis (ALS), preceding the global degeneration of motor axons and being accompanied by new axonal sprouting within the same axonal arbor. Some aspects of ALS onset and progression seem to be affected by sex in animal models of the disease. However, whether there are sex-specific differences in the pattern or time course of NMJ loss and repair within single motor axons remains unknown. We performed further analysis of a previously published <i>in vivo</i> dataset, obtained from male and female SOD1<sup>G37R</sup> mice. We found that NMJ losses are as frequent in male and female motor axons but, intriguingly, axonal sprouting is more frequent in female than male mice, resulting in a net increase of axonal arborization. Interestingly, these numerous new axonal branches in female mice are associated with a slightly faster decline in grip strength, increased NMJ denervation, and reduced &#x3b1;-motor neuron survival. Collectively, these results suggest that excessive axonal sprouting and motor-unit (MU) expansion in female SOD1<sup>G37R</sup> mice are maladaptive during ALS progression.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Martineau et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martineau</LastName><ForeName>&#xc9;ric</ForeName><Initials>&#xc9;</Initials><Identifier Source="ORCID">0000-0002-5503-0798</Identifier><AffiliationInfo><Affiliation>D&#xe9;partement de neurosciences, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qu&#xe9;bec H3C 3J7, Canada eric.martineau.3@umontreal.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Montr&#xe9;al, Qu&#xe9;bec H3T 1C5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Polo</LastName><ForeName>Adriana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1430-0760</Identifier><AffiliationInfo><Affiliation>D&#xe9;partement de neurosciences, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qu&#xe9;bec H3C 3J7, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qu&#xe9;bec H2X 0A9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vande Velde</LastName><ForeName>Christine</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-5926-1529</Identifier><AffiliationInfo><Affiliation>D&#xe9;partement de neurosciences, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qu&#xe9;bec H3C 3J7, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de l'Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qu&#xe9;bec H2X 0A9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robitaille</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de neurosciences, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qu&#xe9;bec H3C 3J7, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Groupe de Recherche sur le Syst&#xe8;me Nerveux Central, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Qu&#xe9;bec, H3C 1J7, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MOP-111070</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant><Grant><GrantID>PJT-376483</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>eNeuro</MedlineTA><NlmUniqueID>101647362</NlmUniqueID><ISSNLinking>2373-2822</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">motor-unit</Keyword><Keyword MajorTopicYN="N">neuromuscular junction</Keyword><Keyword MajorTopicYN="N">reinnervation</Keyword><Keyword MajorTopicYN="N">sex-specific differences</Keyword><Keyword MajorTopicYN="N">superoxide dismutase</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32033983</ArticleId><ArticleId IdType="pmc">PMC7044502</ArticleId><ArticleId IdType="doi">10.1523/ENEURO.0388-19.2020</ArticleId><ArticleId IdType="pii">ENEURO.0388-19.2020</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Armstrong GA, Drapeau P (2013a) Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS. Hum Mol Genet 22:4282&#x2013;4292. 10.1093/hmg/ddt278</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt278</ArticleId><ArticleId IdType="pubmed">23771027</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong GA, Drapeau P (2013b) Calcium channel agonists protect against neuromuscular dysfunction in a genetic model of TDP-43 mutation in ALS. J Neurosci 33:1741&#x2013;1752. 10.1523/JNEUROSCI.4003-12.2013</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4003-12.2013</ArticleId><ArticleId IdType="pmc">PMC6618732</ArticleId><ArticleId IdType="pubmed">23345247</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacabelos D, Ram&#xed;rez-N&#xfa;&#xf1;ez O, Granado-Serrano AB, Torres P, Ayala V, Moiseeva V, Povedano M, Ferrer I, Pamplona R, Portero-Otin M, Boada J (2016) Early and gender-specific differences in spinal cord mitochondrial function and oxidative stress markers in a mouse model of ALS. Acta Neuropathol Commun 4:3. 10.1186/s40478-015-0271-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0271-6</ArticleId><ArticleId IdType="pmc">PMC4711180</ArticleId><ArticleId IdType="pubmed">26757991</ArticleId></ArticleIdList></Reference><Reference><Citation>Chand KK, Lee KM, Lee JD, Qiu H, Willis EF, Lavidis NA, Hilliard MA, Noakes PG (2018) Defects in synaptic transmission at the neuromuscular junction precede motor deficits in a TDP-43(Q331K) transgenic mouse model of amyotrophic lateral sclerosis. FASEB J 32:2676&#x2013;2689. 10.1096/fj.201700835R</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201700835R</ArticleId><ArticleId IdType="pubmed">29295857</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Zhang B, Chen R, Tang L, Liu R, Yang Y, Yang Y, Liu X, Ye S, Zhan S, Fan D (2015) Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China. J Neurol Neurosurg Psychiatry 86:1075&#x2013;1081. 10.1136/jnnp-2015-310471</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310471</ArticleId><ArticleId IdType="pubmed">26124198</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark JA, Southam KA, Blizzard CA, King AE, Dickson TC (2016) Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. J Chem Neuroanat 76:35&#x2013;47. 10.1016/j.jchemneu.2016.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2016.03.003</ArticleId><ArticleId IdType="pubmed">27038603</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantes M, McComas A (1991) The extent and time course of motoneuron involvement in amyotrophic lateral sclerosis. Muscle Nerve 14:416&#x2013;421. 10.1002/mus.880140506</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880140506</ArticleId><ArticleId IdType="pubmed">1870632</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jong SW, Huisman MH, Sutedja NA, van der Kooi AJ, de Visser M, Schelhaas HJ, Fischer K, Veldink JH, van den Berg LH (2012) Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: A population-based study. Am J Epidemiol 176:233&#x2013;239. 10.1093/aje/kws015</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kws015</ArticleId><ArticleId IdType="pubmed">22791740</ArticleId></ArticleIdList></Reference><Reference><Citation>Dengler R, Konstanzer A, K&#xfc;ther G, Hesse S, Wolf W, Struppler A (1990) Amyotrophic lateral sclerosis: Macro-EMG and twitch forces of single motor units. Muscle Nerve 13:545&#x2013;550. 10.1002/mus.880130612</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880130612</ArticleId><ArticleId IdType="pubmed">2366827</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M, Nerbonne JM, Lichtman JW, Sanes JR (2000) Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28:41&#x2013;51. 10.1016/s0896-6273(00)00084-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0896-6273(00)00084-2</ArticleId><ArticleId IdType="pubmed">11086982</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, Khan J, Polak MA, Glass JD (2004) Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp Neurol 185:232&#x2013;240. 10.1016/j.expneurol.2003.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayworth CR, Gonzalez-Lima F (2009) Pre-symptomatic detection of chronic motor deficits and genotype prediction in congenic B6.SOD1(G93A) ALS mouse model. Neuroscience 164:975&#x2013;985. 10.1016/j.neuroscience.2009.08.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2009.08.031</ArticleId><ArticleId IdType="pmc">PMC2783710</ArticleId><ArticleId IdType="pubmed">19699279</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J, Putman CT, Gordon T (2009) Progressive motor unit loss in the G93A mouse model of amyotrophic lateral sclerosis is unaffected by gender. Muscle Nerve 39:318&#x2013;327. 10.1002/mus.21160</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21160</ArticleId><ArticleId IdType="pubmed">19208415</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiman-Patterson TD, Deitch JS, Blankenhorn EP, Erwin KL, Perreault MJ, Alexander BK, Byers N, Toman I, Alexander GM (2005) Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS. J Neurol Sci 236:1&#x2013;7. 10.1016/j.jns.2005.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2005.02.006</ArticleId><ArticleId IdType="pubmed">16024047</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC (2011) Amyotrophic lateral sclerosis. Lancet 377:942&#x2013;955.</Citation><ArticleIdList><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Magran&#xe8; J, Starkov AA, Manfredi G (2012) The mitochondrial calcium regulator cyclophilin D is an essential component of oestrogen-mediated neuroprotection in amyotrophic lateral sclerosis. Brain 135:2865&#x2013;2874. 10.1093/brain/aws208</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws208</ArticleId><ArticleId IdType="pmc">PMC3437032</ArticleId><ArticleId IdType="pubmed">22961554</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalancette-Hebert M, Sharma A, Lyashchenko AK, Shneider NA (2016) Gamma motor neurons survive and exacerbate alpha motor neuron degeneration in ALS. Proc Natl Acad Sci USA 113:E8316&#x2013;E8325. 10.1073/pnas.1605210113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1605210113</ArticleId><ArticleId IdType="pmc">PMC5187676</ArticleId><ArticleId IdType="pubmed">27930290</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Masson G, Przedborski S, Abbott LF (2014) A computational model of motor neuron degeneration. Neuron 83:975&#x2013;988. 10.1016/j.neuron.2014.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.07.001</ArticleId><ArticleId IdType="pmc">PMC4167823</ArticleId><ArticleId IdType="pubmed">25088365</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Pattamatta A, Zu T, Reid T, Bardhi O, Borchelt DR, Yachnis AT, Ranum LP (2016) C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS/FTD. Neuron 90:521&#x2013;534. 10.1016/j.neuron.2016.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.005</ArticleId><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobsiger CS, Boillee S, McAlonis-Downes M, Khan AM, Feltri ML, Yamanaka K, Cleveland DW (2009) Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice. Proc Natl Acad Sci USA 106:4465&#x2013;4470. 10.1073/pnas.0813339106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0813339106</ArticleId><ArticleId IdType="pmc">PMC2657393</ArticleId><ArticleId IdType="pubmed">19251638</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobsiger CS, Boill&#xe9;e S, Pozniak C, Khan AM, McAlonis-Downes M, Lewcock JW, Cleveland DW (2013) C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice. Proc Natl Acad Sci USA 110:E4385&#x2013;E4392. 10.1073/pnas.1318309110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1318309110</ArticleId><ArticleId IdType="pmc">PMC3831990</ArticleId><ArticleId IdType="pubmed">24170856</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjaly ZR, Scott KM, Abhinav K, Wijesekera L, Ganesalingam J, Goldstein LH, Janssen A, Dougherty A, Willey E, Stanton BR, Turner MR, Ampong MA, Sakel M, Orrell RW, Howard R, Shaw CE, Leigh PN, Al-Chalabi A (2010) The sex ratio in amyotrophic lateral sclerosis: A population based study. Amyotroph Lateral Scler 11:439&#x2013;442. 10.3109/17482961003610853</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482961003610853</ArticleId><ArticleId IdType="pmc">PMC6485484</ArticleId><ArticleId IdType="pubmed">20225930</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau E, Di Polo A, Vande Velde C, Robitaille R (2018) Dynamic neuromuscular remodeling precedes motor-unit loss in a mouse model of ALS. eLife 7:e41973 10.7554/eLife.41973</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.41973</ArticleId><ArticleId IdType="pmc">PMC6234026</ArticleId><ArticleId IdType="pubmed">30320556</ArticleId></ArticleIdList></Reference><Reference><Citation>McComas AJ, Sica RE, Campbell MJ, Upton AR (1971) Functional compensation in partially denervated muscles. J Neurol Neurosurg Psychiatry 34:453&#x2013;460. 10.1136/jnnp.34.4.453</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.34.4.453</ArticleId><ArticleId IdType="pmc">PMC493831</ArticleId><ArticleId IdType="pubmed">4938133</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, Henderson RD (2010) Effects of gender in amyotrophic lateral sclerosis. Gend Med 7:557&#x2013;570. 10.1016/j.genm.2010.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genm.2010.11.010</ArticleId><ArticleId IdType="pubmed">21195356</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesci P, Za&#xef;di S, Lobsiger CS, Millecamps S, Escartin C, Seilhean D, Sato H, Mallat M, Boill&#xe9;e S (2015) System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice. Brain 138:53&#x2013;68. 10.1093/brain/awu312</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu312</ArticleId><ArticleId IdType="pmc">PMC4441079</ArticleId><ArticleId IdType="pubmed">25384799</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney EB, Hobo B, De Winter F, Verhaagen J (2017) Expression of a mutant SEMA3A protein with diminished signalling capacity does not alter ALS-related motor decline, or confer changes in NMJ plasticity after BotoxA-induced paralysis of male gastrocnemic muscle. PLoS One 12:e0170314. 10.1371/journal.pone.0170314</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0170314</ArticleId><ArticleId IdType="pmc">PMC5245795</ArticleId><ArticleId IdType="pubmed">28103314</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacelli C, Gigu&#xe8;re N, Bourque MJ, L&#xe9;vesque M, Slack RS, Trudeau LE (2015) Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons. Curr Biol 25:2349&#x2013;2360. 10.1016/j.cub.2015.07.050</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2015.07.050</ArticleId><ArticleId IdType="pubmed">26320949</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfohl SR, Halicek MT, Mitchell CS (2015) Characterization of the contribution of genetic background and gender to disease progression in the SOD1 G93A mouse model of amyotrophic lateral sclerosis: A meta-analysis. J Neuromuscul Dis 2:137&#x2013;150. 10.3233/JND-140068</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JND-140068</ArticleId><ArticleId IdType="pmc">PMC4652798</ArticleId><ArticleId IdType="pubmed">26594635</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun S, Santos AF, Saxena S, Xu L, Caroni P (2006) Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci 9:408&#x2013;419. 10.1038/nn1653</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1653</ArticleId><ArticleId IdType="pubmed">16474388</ArticleId></ArticleIdList></Reference><Reference><Citation>Riar AK, Burstein SR, Palomo GM, Arreguin A, Manfredi G, Germain D (2017) Sex specific activation of the ER&#x3b1; axis of the mitochondrial UPR (UPRmt) in the G93A-SOD1 mouse model of familial ALS. Hum Mol Genet 26:1318&#x2013;1327. 10.1093/hmg/ddx049</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx049</ArticleId><ArticleId IdType="pmc">PMC6075578</ArticleId><ArticleId IdType="pubmed">28186560</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivner MH, Liu S, Quarles B, Fleenor B, Shen C, Pan J, Mei L (2017) Agrin and low-density lipoprotein-related receptor protein 4 antibodies in amyotrophic lateral sclerosis patients. Muscle Nerve 55:430&#x2013;432. 10.1002/mus.25438</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25438</ArticleId><ArticleId IdType="pmc">PMC5318258</ArticleId><ArticleId IdType="pubmed">27756107</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney J, Fogh I, Westeneng HJ, Vajda A, McLaughlin R, Heverin M, Jones A, van Eijk R, Calvo A, Mazzini L, Shaw C, Morrison K, Shaw PJ, Robberecht W, Van Damme P, Al-Chalabi A, van den Berg L, Chi&#xf2; A, Veldink J, Hardiman O (2017) C9orf72 expansion differentially affects males with spinal onset amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 88:281. 10.1136/jnnp-2016-314093</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-314093</ArticleId><ArticleId IdType="pubmed">27663272</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmied A, Pouget J, Vedel JP (1999) Electromechanical coupling and synchronous firing of single wrist extensor motor units in sporadic amyotrophic lateral sclerosis. Clin Neurophysiol 110:960&#x2013;974. 10.1016/S1388-2457(99)00032-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1388-2457(99)00032-2</ArticleId><ArticleId IdType="pubmed">10400212</ArticleId></ArticleIdList></Reference><Reference><Citation>Shneider NA, Brown MN, Smith CA, Pickel J, Alvarez FJ (2009) Gamma motor neurons express distinct genetic markers at birth and require muscle spindle-derived GDNF for postnatal survival. Neural Dev 4:42. 10.1186/1749-8104-4-42</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8104-4-42</ArticleId><ArticleId IdType="pmc">PMC2800842</ArticleId><ArticleId IdType="pubmed">19954518</ArticleId></ArticleIdList></Reference><Reference><Citation>Tallon C, Russell KA, Sakhalkar S, Andrapallayal N, Farah MH (2016) Length-dependent axo-terminal degeneration at the neuromuscular synapses of type II muscle in SOD1 mice. Neuroscience 312:179&#x2013;189. 10.1016/j.neuroscience.2015.11.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.11.018</ArticleId><ArticleId IdType="pmc">PMC4691388</ArticleId><ArticleId IdType="pubmed">26592719</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang L, Ma Y, Liu XL, Chen L, Fan DS (2019) Better survival in female SOD1-mutant patients with ALS: A study of SOD1-related natural history. Transl Neurodegener 8:2. 10.1186/s40035-018-0142-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-018-0142-8</ArticleId><ArticleId IdType="pmc">PMC6325854</ArticleId><ArticleId IdType="pubmed">30637102</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay E, Martineau E, Robitaille R (2017) Opposite synaptic alterations at the neuromuscular junction in an ALS mouse model: When motor units matter. J Neurosci 37:8901&#x2013;8918. 10.1523/JNEUROSCI.3090-16.2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3090-16.2017</ArticleId><ArticleId IdType="pmc">PMC6596800</ArticleId><ArticleId IdType="pubmed">28821658</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi F, Siciliano M, Femiano C, Santangelo G, Lunetta C, Calvo A, Moglia C, Marinou K, Ticozzi N, Ferro C, Scial&#xf2; C, Sorar&#xf9; G, Conte A, Falzone YM, Tortelli R, Russo M, Sansone VA, Chi&#xf2; A, Mora G, Silani V, et al. (2019) Comparative analysis of C9orf72 and sporadic disease in a large multicenter ALS population: The effect of male sex on survival of C9orf72 positive patients. Front Neurosci 13:485. 10.3389/fnins.2019.00485</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00485</ArticleId><ArticleId IdType="pmc">PMC6534038</ArticleId><ArticleId IdType="pubmed">31156370</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe H, Atsuta N, Nakamura R, Hirakawa A, Watanabe H, Ito M, Senda J, Katsuno M, Izumi Y, Morita M, Tomiyama H, Taniguchi A, Aiba I, Abe K, Mizoguchi K, Oda M, Kano O, Okamoto K, Kuwabara S, Hasegawa K, et al. (2015) Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener 16:230&#x2013;236. 10.3109/21678421.2014.990036</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.990036</ArticleId><ArticleId IdType="pubmed">25548957</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwiegers P, Lee G, Shaw CA (2014) Reduction in hSOD1 copy number significantly impacts ALS phenotype presentation in G37R (line 29) mice: Implications for the assessment of putative therapeutic agents. J Negat Results Biomed 13:14. 10.1186/1477-5751-13-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-5751-13-14</ArticleId><ArticleId IdType="pmc">PMC4134475</ArticleId><ArticleId IdType="pubmed">25103619</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>